Ali Faraz, CEO of Tenaya Therapeutics ($TNYA), sold shares on the open market eight times over the past year, totaling about $33,336. His most recent sale occurred on February 17, 2026. These $TNYA insider sales rank 10,730th among 11,678 individual insiders in our database, where the average is $8.6 million across roughly 6.4 transactions. Faraz made no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | S | Common Stock | 5032 | $0.64 | 443,404.0000 | 166,505,885 | 1.12% | 0.00% |
| Feb. 17, 2026 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | S | Common Stock | 3979 | $0.64 | 448,436.0000 | 166,505,885 | 0.88% | 0.00% |
| Feb. 17, 2026 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | S | Common Stock | 5851 | $0.64 | 452,415.0000 | 166,505,885 | 1.28% | 0.00% |
| Feb. 3, 2026 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | A | Stock Option (Right to buy) | 952250 | $0.00 | 952,250.0000 | 166,505,885 | 9999.99% | 0.57% |
| Feb. 3, 2026 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | A | Common Stock | 158600 | $0.00 | 458,266.0000 | 166,505,885 | 52.93% | 0.10% |
| Nov. 17, 2025 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | S | Common Stock | 3126 | $1.33 | 299,666.0000 | 166,505,885 | 1.03% | 0.00% |
| Aug. 18, 2025 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | S | Common Stock | 5720 | $1.25 | 311,605.0000 | 87,582,646 | 1.80% | 0.01% |
| Aug. 18, 2025 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | S | Common Stock | 3893 | $1.25 | 307,712.0000 | 87,582,646 | 1.25% | 0.00% |
| Aug. 18, 2025 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | S | Common Stock | 4920 | $1.25 | 302,792.0000 | 87,582,646 | 1.60% | 0.01% |
| May 16, 2025 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | S | Common Stock | 3189 | $0.44 | 317,325.0000 | 87,582,646 | 0.99% | 0.00% |
| March 10, 2025 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | S | Common Stock | 5794 | $0.54 | 324,461.0000 | 87,582,646 | 1.75% | 0.01% |
| March 10, 2025 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | S | Common Stock | 3947 | $0.54 | 320,514.0000 | 87,582,646 | 1.22% | 0.00% |
| Feb. 6, 2025 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | A | Stock Option (Right to Buy) | 161214 | $0.00 | 161,214.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2025 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | D | Stock Option (Right to Buy) | 401390 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2025 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | A | Stock Option (Right to Buy) | 401390 | $0.00 | 401,390.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2025 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | D | Stock Option (Right to Buy) | 353271 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2025 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | A | Stock Option (Right to Buy) | 353271 | $0.00 | 353,271.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2025 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | D | Stock Option (Right to Buy) | 161214 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2025 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | A | Stock Option (Right to buy) | 650000 | $0.00 | 650,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2025 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | A | Common Stock | 34424 | $0.00 | 330,255.0000 | 0 | 11.64% | 0.00% |
| Feb. 6, 2025 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | A | Common Stock | 107500 | $0.00 | 295,831.0000 | 0 | 57.08% | 0.00% |
| Aug. 16, 2024 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | S | Common Stock | 3946 | $2.89 | 188,331.0000 | 0 | 2.05% | 0.00% |
| Aug. 16, 2024 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | S | Common Stock | 5802 | $2.89 | 192,277.0000 | 0 | 2.93% | 0.00% |
| Feb. 23, 2024 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | A | Stock Option (Right to buy) | 505000 | $0.00 | 505,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2024 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | A | Common Stock | 85000 | $0.00 | 198,079.0000 | 0 | 75.17% | 0.00% |
| Feb. 16, 2024 | Tenaya Therapeutics, Inc. | $TNYA | Ali Faraz | Chief Executive Officer | S | Common Stock | 6358 | $5.86 | 113,079.0000 | 0 | 5.32% | 0.00% |